Our finding of a significantly reduced expression of MALAT1 in PDAC is partially contradictory to a previous study that analyzed the clinical significance of MALAT1 in pancreatic cancer using multiple datasets from different public databases (GEO, Oncomine, TCGA) [97]. This evidence concerns the gene MALAT1 and pancreatic neoplasm.